Authorization

DGAP-News: Biom'up announces first US sales in laparoscopy for HEMOBLAST(TM) Bellows and the signing of an exclusive distribution agreement for HEMOBLAST(TM) Bellows in Australia

DGAP-News: Biom'up / Key word(s): Agreement


Biom'up announces first US sales in laparoscopy for HEMOBLAST(TM) Bellows and the signing of an exclusive distribution agreement for HEMOBLAST(TM) Bellows in Australia


15.04.2019 / 08:00



The issuer is solely responsible for the content of this announcement.


Biom'up announces first US sales in laparoscopy for HEMOBLASTTM Bellows and the signing of an exclusive distribution agreement for HEMOBLASTTM Bellows in Australia



Successful launch of the HEMOBLAST Bellows Laparoscopic Applicator in the US, first sales booked in March 2019




Major framework agreement signed with Life Healthcare Distribution ("LHC") for the exclusive distribution of HEMOBLAST Bellows in the sizeable and growing Australian market


Saint-Priest, France, April 15th, 2019 - 8h00 (CET) - Biom'up SA (the "Company »), specializing in surgical hemostasis, announces today first sales on the US market of its HEMOBLAST Bellows Laparoscopic Applicator.

The first kits have been shipped overseas from Saint-Priest (France) production unit and delivered to hospitals earlier in March. The U.S. surgeons are now able to use the hemostatic powder for both open and laparoscopic surgeries with the same patient and surgeon benefits of efficacy, simplicity and rapid availability. The U.S. laparoscopy market, in a growing phase, is estimated at nearly 443,000 surgeries per year[1].
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2019    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
2930